Picture of Stablecoin Development logo

SDEV Stablecoin Development News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapValue Trap

Promote Prescription Ophthalmic Products To U.S. Eyecare Professionals

March 13 (Reuters) - Eyenovia Inc  EYEN.O :
    * NOVABAY PHARMACEUTICALS AND EYENOVIA TO
CO-PROMOTE PRESCRIPTION
OPHTHALMIC PRODUCTS TO U.S. EYECARE PROFESSIONALS
    * NOVABAY PHARMACEUTICALS INC - WILL MARKET EYENOVIA'S
CLOBETASOL
PROPIONATE OPHTHALMIC SUSPENSION 0.05% THROUGH ITS U.S.
PHYSICIAN-DISPENSED CHANNEL
    * NOVABAY PHARMA - EYENOVIA TO MARKET CO'S PRESCRIPTION
AVENOVA
ANTIMICROBIAL LID & LASH SOLUTION THROUGH MYDCOMBI,CLOBETASOL
SALES REPRESENTATIVES

Source text for Eikon:  ID:nGNX9xs8hR 
Further company coverage:  EYEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Stablecoin Development

See all news